Page 559 - ACCCN's Critical Care Nursing

536 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

wcms/publishing.nsf/Content/health-pubhlth-strateg-hiv_hepc-hepc- 265. Fallon MB. Mechanisms of pulmonary vascular complications of liver
index.htm. disease: hepatopulmonary syndrome. J Clin Gastroenterol 2005; 39(4 Suppl
236. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic 2): S138–42.
liver failure. Liver 2002; 22(Suppl. 2): 5–13. 266. Cook DJ, Fuller HD, Guyatt GH. Risk factors for gastrointestinal bleeding in
237. Rahman T, Hodgson H. Clinical management of acute hepatic failure. Intens critically ill patients. New Engl J Med 1994; 330(6): 377–81.
Care Med 2001; 27: 467–76. 267. Ryder SD. Clinical assessment of liver disease. Medicine. 2007; 35(1): 1–4.
238. Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary 268. Sizer E, Wendon J. Acute liver failure. In: Bersten AD, Soni N, eds. Oh’s
system: Other causes of parenchymal liver disease. BMJ 2001; 322(7281): intensive care manual, 6th edn. Oxford: Butterworth Heinemann; 2009.
290–92. 269. Sherlock S, Dooley J. Diseases of the liver and biliary system, 9th edn. London:
239. Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. The mystery of Blackwell; 1995.
liver regeneration. Br J Surg 2002; 89(9): 1089–95. 270. Botta F, Ciannini E, Romagnoli P, Fasoli A, Malfatti F et al. MELD scoring
240. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213(2): 286–300. system is useful for predicting prognosis in patients with liver cirrohosis and
241. Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med is correlated with residual liver function: a European study. Gut 2003; 52(1):
J 2005; 35(1): 45–9. 134–9.
242. Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary 271. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am
system: Acute hepatitis. BMJ 2001; 322(7279): 151–3. 2004; 84(2): 355–73.
243. Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary 272. Kimura S, Yoshioka R, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocya-
systems: Chronic viral hepatitis. BMJ 2001; 322(7280): 219–21. nine green elminination rate detects hepatocellular dysfunction early in septic
244. Kaldor JM, Plant AJ, Thompson SC, Longbottom H, Rowbottom J. The shock and correlates with survival. Crit Care Med 2001; 29(6): 1159–63.
incidence of hepatitis B infection in Australia: an epidemiological review. 273. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split-liver transplanta-
Med J Aust 1996; 165: 322–6. tion in the United States: outcomes of a national survey. Ann Surg 2004;
245. New Zealand Ministry of Health. The feasibility of screening for and surveil- 239(2): 172-81.
lance of hepatitis B in a single geographic area. Wellington, New Zealand: 274. Menon KV, Kamath PS. Managing the complications of cirrhosis. Mayo Clin
New Zealand Ministry of Health; 1996 [cited June 2005]. Available from: Proc 2000; 75(5): 501–9.
http://www.moh.govt.nz/moh.nsf/49b6bf07a4b7346dcc256fb300005 275. Marrero J, Martinez FJ, Hyzy R. Advances in critical care hepatology. Am
a51/e795f5b0cddb25274c256671000c194c/$FILE/hepb.pdf. J Resp Crit Care Med 2003; 168(12): 1421–6.
246. Law MG, Dore GJ, Bath N, Thompson S, Crofts N et al. Modelling hepatitis 276. Christensen T. The treatment of oesophageal varices using a Sengstaken-
C virus incidence, prevalence and long-term sequelae in Australia. Int J Blakemore tube: considerations for nursing practice. Nurs Crit Care 2004;
Epidemiol 2001; 32: 717–24. 9(2): 58–63.
247. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, 277. Rose JDG. Transjugular intrahepatic portosystemic stent shunt. Care of the
viral hepatitis and sexually transmissible infections in Australia: Annual Surveil- Critically Ill 1995; 11(2): 50–52.
lance Report 2009. Sydney, Australia: NCHECR, The University of NSW; 278. Davenport A. Extracorporeal support for patients with hepatic failure. Hemo-
2009. dial Int 2003; 7(3): 256–63.
248. Hepatitis C Virus Projections Working Group. Estimates and projections of the 279. Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin
hepatitis C Virus epidemic in Australia 2006. Sydney, NSW, Australia: National Liver Dis 2008; 28(2): 201–9.
Centre in HIV Epidemiology and Clinical Research, The University of New 280. Lynch S, Kerlin P, Wall D, Ong TH, Shepherd RW et al. The Queensland Liver
South Wales; 2006. Transplant Programme: the first two years. Med J Aust 1987; 147(8): 380–85.
249. New Zealand Government Ministry of Health. Action on hepatic C preven- 281. Gane E, McCall J, Streat S, Gunn K, Yeong ML et al. Liver transplantation in
tion. Wellington, NZ: New Zealand Government; 2002. New Zealand: the first four years. N Z Med J 2002; 115(1159): U120.
250. Foston TP, Carpentar D. Acute liver failure. Crit Care Nurs Clin North Am 282. Lynch S, Balderson G. ANZLT Registry Report. Brisbane, QLD: Australian and
2010; 22(3): 395–402. New Zealand Liver Transplant Registry; 2010.
251. O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syn- 283. The Transplant Society of Australia and New Zealand (TSANZ). Organ trans-
dromes. Lancet 1993; 342(8866): 273–5. planation from deceased donors: Consensus statement on eligibility criteria and
252. Maynard ND, Bihari DJ, Dalton N, Beale R, Smithies MN, Mason RC. Liver allocation protocols. Sydney: TSANZ; 2010.
function and splanchnic ischemia in critically ill patients. Chest 1997; 111: 284. O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastro-
180–87. enterology 2008; 134(6): 1764–76.
253. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocya- 285. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according
nine green plasma dissappearance rate in critically ill patients. Chest 2002; to size of waiting list: impact of organ allocation and patient outcomes.
122(55): 1715–20. JAMA 2004 21; 291(15): 1871–4.
254. Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 2000; 4(1): 286. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model
25–45. to predict poor survival in patients undergoing transjugular intrahepatic
255. Butterworth RF. Pathogenesis of hepatic encephalopathy: update on molecu- portosystemic shunts. Hepatology 2000; 31(4): 864–71.
lar mechanisms. Indian J Gastroenterol 2003; 22(Suppl 2):S11–16. 287. Freeman RB, Jr., Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion
256. Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encepha- RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004;
lopathy in acute liver failure. Semin Liver Dis 2003; 23(3): 259–69. 4(Suppl 9): 114–31.
257. Haussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopa- 288. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatol-
thy. Gut 2008; 57(8): 1156–65. ogy 2007; 45(3): 797–805.
258. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC et al. Com- 289. Sizer E, Wendon J. Liver transplantation. In: Bersten AD, Soni N, eds. Oh’s
parison of lactulose and neomycin in the treatment of chronic portal- intensive care manual, 6th edn. Oxford: Butterworth Heinemann; 2009.
systemic encephalopathy. A double blind controlled trial. Gastroenterology 290. Maletic-Staschak S. Orthotopic liver transplantation. The surgical procedure.
1977; 72(4 Pt 1): 573–83. AORN J 1984; 39(1): 35–9.
259. Ortiz M, Cordoba J, Doval E, Jacas C, Pujadas F et al. Development of a 291. Smith SE, Brumm J, Crim BJ. Liver transplantation. Semin Perioper Nurs 1992;
clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007; 1(1): 10–19.
26(6): 859–67. 292. Reddy KS, Johnston TD, Putnam LA, Isley M, Ranjan D. Piggyback technique
260. Hassanein TI, Hilsabeck RC, Perry W. Introduction to the Hepatic Encepha- and selective use of veno-venous bypass in adult orthotopic liver transplanta-
lopathy Scoring Algorithm (HESA). Dig Dis Sci 2008; 53(2): 529–38. tion. Clin Transplant 2000; 14(4 Pt 2): 370–74.
261. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic 293. Urbani L, Campatelli A, Romagnoli J, Catalano G, Sartoni G et al. T-tube
encephalopathy – definition, nomenclature, diagnosis, and quantification: removal after liver transplantation: a new technique that reduces biliary
final report of the working party at the 11th World Congresses of Gastroen- complications. Transplantation 2002; 74(3): 410–13.
terology, Vienna, 1998. Hepatology 2002; 35(3): 716–21. 294. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC et al. The use of
262. Dagher L, Moore K. The hepatorenal syndrome. Gut 2001; 49: 729–37. the T tube after orthotopic liver transplantation. Transplantation 1996; 61(2):
263. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003; 258–61.
362: 1819–27. 295. Shimoda M, Saab S, Morrisey M, Ghobrial RM, Farmer DG et al. A cost-
264. Sharara AI, Rockey DC. Medical prognosis. Gastroesophageal variceal hem- effectiveness analysis of biliary anastomosis with or without T-tube after
orrhage. New Engl J Med 2001; 345(9): 669–81. orthotopic liver transplantation. Am J Transplant 2001; 1(2): 157–61.